Advertisement
Research Article

Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy

  • Michele L. Pearson,

    Affiliation: Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Joseph V. Selby,

    Affiliation: Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America

    X
  • Kenneth A. Katz,

    Affiliation: HIV, STD, and Hepatitis Branch, Health and Human Services Agency, County of San Diego, San Diego, California, United States of America

    X
  • Virginia Cantrell,

    Affiliation: Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America

    X
  • Christopher R. Braden,

    Affiliation: Division of Food, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Monica E. Parise,

    Affiliation: Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Christopher D. Paddock,

    Affiliation: Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Michael R. Lewin-Smith,

    Affiliation: Environmental Pathology, Joint Pathology Center, Silver Spring, Maryland, United States of America

    X
  • Victor F. Kalasinsky,

    Affiliation: Office of Research & Development, United States Department of Veterans Affairs, Washington, District of Columbia, United States of America

    X
  • Felicia C. Goldstein,

    Affiliation: Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, United States of America

    X
  • Allen W. Hightower,

    Affiliation: Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Arthur Papier,

    Affiliation: Department of Dermatology, University of Rochester School of Medicine, Rochester, New York, United States of America

    X
  • Brian Lewis,

    Affiliation: Division of Health Studies, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, United States of America

    X
  • Sarita Motipara,

    Affiliation: Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America

    X
  • Mark L. Eberhard mail,

    mle1@cdc.gov

    Affiliation: Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • for the Unexplained Dermopathy Study Team

    Additional membership of the Unexplained Dermopathy Study Team is provided in the Acknowledgments.

    X
  • Published: January 25, 2012
  • DOI: 10.1371/journal.pone.0029908

About the Authors

Michele L. Pearson
Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Joseph V. Selby, Virginia Cantrell, Sarita Motipara
Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America
Kenneth A. Katz
HIV, STD, and Hepatitis Branch, Health and Human Services Agency, County of San Diego, San Diego, California, United States of America
Christopher R. Braden
Division of Food, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Monica E. Parise, Allen W. Hightower, Mark L. Eberhard
Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Christopher D. Paddock
Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Michael R. Lewin-Smith
Environmental Pathology, Joint Pathology Center, Silver Spring, Maryland, United States of America
Victor F. Kalasinsky
Office of Research & Development, United States Department of Veterans Affairs, Washington, District of Columbia, United States of America
Felicia C. Goldstein
Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, United States of America
Arthur Papier
Department of Dermatology, University of Rochester School of Medicine, Rochester, New York, United States of America
Brian Lewis
Division of Health Studies, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, United States of America

Corresponding Author

Email: mle1@cdc.gov

Competing Interests

One or more of the authors are employed by a commercial, not-for-profit entity (Kaiser Permanente). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: M. Pearson JS CB KK MLE CP ML-S VK CD M. Parise BL. Performed the experiments: KK VC M. Pearson CP SZ ML-S VK LB PA GL MES W-JS PW JH GL SM EL IM FM. Analyzed the data: AB BF AWH AP FCG. Contributed reagents/materials/analysis tools: CP SZ ML-S VK LB GL MES W-JS PW IM JH SM. Wrote the paper: M. Pearson JS CP ML-S.